Categories: Manufacturers (D)

Nectar Lifesciences Ltd, SCO 38-39, Sector 9d, Chandigarh 160009, India

Company Name : Nectar Lifesciences Ltd

Address : SCO 38-39, Sector 9d, Chandigarh 160009, India

Tel No: 91172-3047777

Website : http://www.neclife.com/

Company Profile

Nectar Lifesciences Ltd. (NLL) is a knowledge driven organization which constitutes a vital part of fast growing Indian Pharmaceutical Industry. In a short span of existence, NLL has today emerged as 365 ranked organization amongst the top 500 Indian Corporates & is currently among top 25 fore runners of the Indian Pharmaceutical industry with a top 5 ranking in the Indian Bulk Drug Industry from a stand alone Active Pharmaceutical Ingredients (API Manufacture) perspective.NLL has transformed itself to being the most integrated player in the Global Cephalosprins Industry within Anti Infective Therapeutic segment.NLL is catapulting itself into Cephalosporin Formulations in a defining way by entering lucrative regulated markets like US, European Union & Japan to name a few with 11 State of Art manufacturing facilities spread across the States of Punjab, Himachal Pradesh Jammu & Kashmir with compliance to global standards of cGMP, Environment Health Safety (EHS) as well as pool of thousands of highly skilled, knowledgeable, competent qualified work force at all levels. Growth through human capital is the principal unlying driver of NLL’s success in past as well as in the future with global economy undergoing rapid changes driven by Pharma emerging markets like India, China, Korea, Brazil, South Africa, Russia just to name a few. NLL has a very sharp focus on these exciting rapidly expanding economies.Sustained growth which enshrines strict adherence to corporate governance, value system cultural ethos, mingled with respect & adherence to tenets of intellectual property make NLL into the most favoured organization to align with both in terms of conduct of business as well as a prime candidate in CRAMS space in Lifesciences which is the main stay of the Indian Lifesciences Industry that has witnessed excellent growth in the last 5 years.Human suffering alleviation at affordable costs will continue to drive both developed & developing nations in terms of greater access to medication NLL is committed to play its role in making this happen in best possible way. We invite you to be a part of us whilst we nurture, enrich & care to contribute our bit to the society at large by way of small contribution in our own way to give back to the society what we’ve taken from it.

The Pharma Times News Bureau

Recent Posts

Kaivalyadhama to Host 11th International Conference on Yoga in Cancer Care, Uniting Global Experts to Explore Yoga’s Role in Holistic Cancer Support

Lonavala, November 12, 2024: As the global cancer burden rises to 30 million cases by…

17 hours ago

Sringeri Sharada Equitas Hospital Revolutionizing Cancer Care with the Launch of Low-cost, High Quality Radiation Therapy

The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…

17 hours ago

From Pain to Relief: How endoscopic spine surgery enhances patient outcomes

By DR UMESH SRIKANTHA, Senior Consultant - Neurosurgery, Head of Spine Services, Aster RV Hospital …

2 days ago

Henkel India Unveils Dedicated Researchers’ World Lab in India

Pune, November 11, 2024: Henkel Adhesives Technologies India Private Limited (Henkel India) announces the opening…

2 days ago

Esaote Group Expands Production in India

Noida, November 08, 2024: Esaote Group, a leading Italian innovator in medical imaging - ultrasound,…

5 days ago

In Q2 FY25, AGI Greenpac Limited posts EBITDA of ₹166 crore up by 20% Y-o-Y and PAT of Rs ₹72 crore up by 28%

Gurugram, November 08, 2024: AGI Greenpac Limited, a focused Packaging Products company, today announced its financial…

5 days ago